224
Participants
Start Date
April 24, 2024
Primary Completion Date
April 25, 2026
Study Completion Date
December 1, 2027
InterVapor®-System
"The InterVapor System uses heated water vapor to ablate the airways and parenchyma within targeted regions of the lung. Lung remodeling occurs after an initial localized inflammatory response and a subsequent healing and repair. The remodeling of the tissue results in reductions in tissue and air volume in the targeted regions of the lung. The remodeled lung tissue does not re-inflate as a result of collateral ventilation.~The lung volume reduction of diseased hyper-inflated lung segments after InterVapor treatment is expected to increase elastic recoil by reducing the most compliant segments of the lung, decompressing segments of healthier lung allowing for alveolar recruitment, and improving the mechanical efficiency of the respiratory muscles. These mechanical changes are anticipated to improve pulmonary function, exercise capacity and quality of life."
RECRUITING
Charité Campus Benjamin Franklin, Berlin
RECRUITING
Gemeinschaftskrankenhaus Havelhöhe gGmbH Klinik für Anthroposophische Medizin, Berlin
RECRUITING
Helios Hanseklinikum Stralsund, Stralsund
RECRUITING
Lungenfachklinik Immenhausen, Immenhausen
NOT_YET_RECRUITING
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik II, Bonn
RECRUITING
KlinKlinikuim Lüdenscheid, Klinik für Pneumologie, internistische Intensivmedizin, Infektiologie und Schlafmedizin, Lüdenscheid
RECRUITING
Lungenklinik Hemer, Hemer
NOT_YET_RECRUITING
Asklepios Klinik Langen, Klinik für Innere Medizin III, Langen
RECRUITING
Thoraxklinik University of Heidelberg, Heidelberg
RECRUITING
Thoraxzentrum Bezirk Unterfranken, Münnerstadt
RECRUITING
Pneumologische Universitätsklinik Ruhrlandklinik, Essen
RECRUITING
Universitätsklinikum Halle (Saale), Halle
IHF GmbH - Institut für Herzinfarktforschung
OTHER